Literature DB >> 20499259

Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods.

Jianxin Cheng1, Guixia Liu, Jing Zhang, Zhejun Xu, Yun Tang.   

Abstract

To probe the selective mechanism of agonists binding to three opioid receptor subtypes, ligand-based and receptor-based methods were implemented together and subtype characteristics of opioid agonists were clearly described. Three pharmacophore models of opioid agonists were generated by the Catalyst/HypoGen program. The best pharmacophore models for μ, δ and κ agonists contained four, five and five features, respectively. Meanwhile, the three-dimensional structures of three receptor subtypes were modeled on the basis of the crystal structure of β2-adrenergic receptor, and molecular docking was conducted further. According to these pharmacophore models and docking results, the similarities and differences among agonists of three subtypes were identified. μ or δ agonists, for example, could form one hydrogen bond separately with Tyr129 and Tyr150 at TMIII, whereas κ ones formed a π-π interaction in that place. These findings may be crucial for the development of novel selective analgesic drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20499259     DOI: 10.1007/s00894-010-0745-1

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  74 in total

1.  QSAR study of 4-phenylpiperidine derivatives as mu opioid agonists by neural network method.

Authors:  Xing-hai Wang; Yun Tang; Qiong Xie; Zhui-bai Qiu
Journal:  Eur J Med Chem       Date:  2006-01-05       Impact factor: 6.514

2.  Ligand recognition in mu opioid receptor: experimentally based modeling of mu opioid receptor binding sites and their testing by ligand docking.

Authors:  T Sagara; H Egashira; M Okamura; I Fujii; Y Shimohigashi; K Kanematsu
Journal:  Bioorg Med Chem       Date:  1996-12       Impact factor: 3.641

3.  Location of regions of the opioid receptor involved in selective agonist binding.

Authors:  K Fukuda; S Kato; K Mori
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

4.  Ontogeny of opioid pharmacology and receptors: high and low affinity site differences.

Authors:  A Z Zhang; G W Pasternak
Journal:  Eur J Pharmacol       Date:  1981-07-17       Impact factor: 4.432

5.  Enantiomers of 2-[(Acylamino)ethyl]-1,4-benzodiazepines, potent ligands of kappa-opioid receptor: chiral chromatographic resolution, configurational assignment and biological activity.

Authors:  O Azzolina; S Collina; L Linati; M Anzini; A Cappelli; M A Scheideler; M Sbacchi
Journal:  Chirality       Date:  2001       Impact factor: 2.437

6.  Identification of potent phenyl imidazoles as opioid receptor agonists.

Authors:  Henry J Breslin; Chaozhong Cai; Tamara A Miskowski; Santosh V Coutinho; Sui-Po Zhang; Pamela Hornby; Wei He
Journal:  Bioorg Med Chem Lett       Date:  2006-02-17       Impact factor: 2.823

7.  Derivation of rules for comparative protein modeling from a database of protein structure alignments.

Authors:  A Sali; J P Overington
Journal:  Protein Sci       Date:  1994-09       Impact factor: 6.725

8.  Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.

Authors:  Anne-Cécile Hiebel; Yong Sok Lee; Edward Bilsky; Denise Giuvelis; Jeffrey R Deschamps; Damon A Parrish; Mario D Aceto; Everette L May; Louis S Harris; Andrew Coop; Christina M Dersch; John S Partilla; Richard B Rothman; Kejun Cheng; Arthur E Jacobson; Kenner C Rice
Journal:  J Med Chem       Date:  2007-07-11       Impact factor: 7.446

9.  Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesic.

Authors:  Johannes Schütz; Mariana Spetea; Martin Koch; Mario D Aceto; Louis S Harris; Andrew Coop; Helmut Schmidhammer
Journal:  J Med Chem       Date:  2003-09-11       Impact factor: 7.446

10.  Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception.

Authors:  E E Codd; R P Shank; J J Schupsky; R B Raffa
Journal:  J Pharmacol Exp Ther       Date:  1995-09       Impact factor: 4.030

View more
  3 in total

1.  In silico investigation of interactions between human cannabinoid receptor-1 and its antagonists.

Authors:  Guanglin Kuang; Guoping Hu; Xianqiang Sun; Weihua Li; Guixia Liu; Yun Tang
Journal:  J Mol Model       Date:  2012-03-09       Impact factor: 1.810

2.  Consensus 3D model of μ-opioid receptor ligand efficacy based on a quantitative Conformationally Sampled Pharmacophore.

Authors:  Jihyun Shim; Andrew Coop; Alexander D MacKerell
Journal:  J Phys Chem B       Date:  2011-05-12       Impact factor: 2.991

3.  Molecular switches of the κ opioid receptor triggered by 6'-GNTI and 5'-GNTI.

Authors:  Jianxin Cheng; Xianqiang Sun; Weihua Li; Guixia Liu; Yaoquan Tu; Yun Tang
Journal:  Sci Rep       Date:  2016-01-08       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.